Logo
Apparel & Fashion

Description

Gefitinib Tablets 250mg represent a specialized targeted therapy medication designed specifically for treating non-small cell lung cancer by inhibiting epidermal growth factor receptor tyrosine kinase activity. This sophisticated mechanism precisely blocks the cellular signals that drive cancer proliferation and survival, offering a more focused approach to cancer management. Each tablet contains 250mg of gefitinib as the active pharmaceutical ingredient, manufactured to ensure consistent dosage delivery and reliable therapeutic performance. The medication demonstrates particular effectiveness for patients whose cancer testing confirms specific EGFR mutations, providing a personalized treatment strategy that aligns with modern precision medicine principles. Healthcare professionals value these tablets for their ability to target cancer cells with accuracy while potentially minimizing impact on healthy cells.

This medication finds primary application within oncology departments across ...
Gefitinib Tablets 250mg represent a specialized targeted therapy medication designed specifically for treating non-small cell lung cancer by inhibiting epidermal growth factor receptor tyrosine kinase activity. This sophisticated mechanism precisely blocks the cellular signals that drive cancer proliferation and survival, offering a more focused approach to cancer management. Each tablet contains 250mg of gefitinib as the active pharmaceutical ingredient, manufactured to ensure consistent dosage delivery and reliable therapeutic performance. The medication demonstrates particular effectiveness for patients whose cancer testing confirms specific EGFR mutations, providing a personalized treatment strategy that aligns with modern precision medicine principles. Healthcare professionals value these tablets for their ability to target cancer cells with accuracy while potentially minimizing impact on healthy cells.

This medication finds primary application within oncology departments across various healthcare settings including comprehensive hospitals, specialized cancer treatment centers, and respiratory medicine clinics. It serves medical oncologists, pulmonologists, and respiratory specialists managing NSCLC cases with laboratory-confirmed EGFR mutations. The pharmaceutical supply chain encompassing distributors, wholesalers, and hospital procurement teams ensures this critical medication reaches healthcare providers worldwide. Oncology pharmacies and treatment facilities maintain adequate inventory to support both initial treatment cycles and ongoing maintenance therapy for eligible patients, establishing it as a fundamental component in contemporary cancer care protocols and treatment guidelines.

Business partners benefit from our dependable supply network that guarantees consistent availability of Gefitinib Tablets 250mg to meet market demands. We implement rigorous quality control measures throughout manufacturing and packaging processes, ensuring products comply with international pharmaceutical standards and regulatory requirements. The product's established efficacy in managing EGFR-positive NSCLC builds confidence among medical professionals and patients. We provide competitive pricing for volume orders while maintaining transparent business operations for pharmaceutical distributors and wholesalers, supporting their market operations with reliable product access and professional partnership.

Key Features:
- Contains 250mg gefitinib per tablet as the precise active ingredient
- Functions as EGFR tyrosine kinase inhibitor targeting specific cancer mechanisms
- Manufactured following strict quality protocols meeting international standards
- Available in commercial packaging configurations for distribution needs
- Supported by complete documentation including quality certificates

Benefits:
- Provides targeted therapy for EGFR mutation-positive NSCLC patients
- Offers precision treatment approach with potential reduced side effects
- Delivers consistent therapeutic performance through quality manufacturing
- Supports healthcare providers with reliable medication for cancer care
- Enables distributors to meet medical community needs with trusted product

Specifications

Additional Information
Country of OriginIndia

Application

Gefitinib 250mg tablets serve as essential targeted therapy in oncology practice, specifically treating non-small cell lung cancer patients with confirmed EGFR mutations. These tablets provide a precision medicine approach that inhibits cancer cell growth signals while potentially sparing healthy cells from damage commonly associated with traditional chemotherapy treatments. Medical facilities including hospitals, cancer centers, and specialized clinics incorporate Gefitinib tablets into treatment protocols for eligible NSCLC patients. Distributors and wholesalers maintain consistent supplies to support healthcare providers in delivering continuous care to patients undergoing targeted therapy regimens in both inpatient and outpatient settings. - First-line treatment for metastatic non-small cell lung cancer with confirmed EGFR mutations - Maintenance therapy following initial cancer treatment response in EGFR-positive patients - Alternative treatment option when conventional chemotherapy proves unsuitable or ineffective - Integration into combination therapy regimens under oncologist supervision - Supportive care for advanced NSCLC patients to manage disease progression and improve outcomes

Trade Details

Available StockIn Stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Custom Terms (manual entry)

Company Profile

Biogenix Pharma UK Limited, Maharashtra
TruBasic
IndiaMaharashtra, India
Manufacturer
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Gefitinib Tablets 250mg EGFR Inhibitor For NSCLC Treatment

Gefitinib Tablets 250mg are EGFR tyrosine kinase inhibitors for treating non-small cell lung cancer, offering reliable targeted therapy for patients with EGFR mutations through consistent quality and precise dosage.

Min. Order Quantity: 1 unit

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

Biogenix Pharma UK Limited
TruBasic
IndiaMaharashtra, India
Manufacturer

More Products From Supplier